San Francisco, 22 November
2018: Based on a report by Grand View Research, Inc.;
the global biopsy devices market is anticipated to reach USD 2.3 billion by 2020. High
demand for effective diagnostic procedures for cancer is anticipated to drive
market growth over the forecast period (2012 to 2020). Rising preference for
less invasive surgeries to reduce post-surgery complications is projected to
bode well for market expansion in near future.
Rising cases of
cancer are expected to surge demand for biopsy procedures. This, in turn, can
fuel demand for advanced devices over the next few years. Growing adoption of
minimally invasive medical procedures owing to less trauma and quick recovery
post-surgery can further augment market. Favorable initiatives by governments
of various nations to curb high costs associated with cancer treatment can fuel
demand for advanced diagnostic procedures. This factor is anticipated to
stimulate market growth during the forecast period.
The worldwide biopsy
devices market can be segregated on the basis of product and region. Based on
product, the market can be categorized into needle-based biopsy guns, needles, guidance
systems, forceps, and others. In 2013, needle based biopsy guns held the largest
market share. Rising demand for these guns to acquire samples from soft tissues
of internal organs such as kidneys, breasts, and lungs can contribute to growth.
In addition, high demand for gentle procurement of cell samples can surge
demand for advanced biopsy devices. This, in turn can fuel growth of segment
over next few years.
Access
Research Report of Biopsy
Devices Market@ www.grandviewresearch.com/industry-analysis/biopsy-devices-industry
The segment can be
divided further into vacuum-assisted, core needle, and fine needle aspiration
devices. Vacuum-assisted devices are expected to register high demand over next
few years. These devices are available in semi-automatic, manual and automatic
with spring loaded mechanism to obtain samples for laboratory testing in
minimally invasive manner. Such devices offer precision and high efficiency in
withdrawal of large volumes and excellent quality tissue samples with minimal
number of passes through the skin.
Similarly,
continual R&D in medical devices is likely boost introduction of various
novel devices and systems such as medical robotic systems in the market. These
robotic guidance systems can increasing total number of surgeries performed by
surgeons. In addition, they can reduce duration of treatment and can curb
patient discomfort. This factor is projected to create positive influence on
global market in the forthcoming years.
Biopsy needles
segment can witness significant growth during the forecast period attributed to
rising preference for disposable needles over their reusable counterparts.
Growing concerns regarding cross-contamination and safety can further augment
growth. Introduction of new disposable biopsy needles such as biopty-cut
(coaxial needle), truguide (core needle), and ostycut (bone needle) can
stimulate growth of the market over the next few years.
Browse more reports of this category by
Grand View Research at: www.grandviewresearch.com/industry/clinical-diagnostics
Regional
segmentation includes Europe, North America, Asia Pacific, Latin America, and
Middle East and Africa. In 2016, North America accounted for largest market
share attributed to presence of major players. It is likely to grow at similar
pace during the forecast period. Rising penetration of technologically advanced
devices such as vacuum assisted biopsy systems can further fuel market. In
addition, rising demand for disposable devices can surge regional market.
Moreover, increasing number of biopsies in U.S. and less stringent regulations
from the U.S. Food and Drug Administration (FDA) to approve medical devices can
further propel regional growth.
Asia Pacific
market is expected to witness significant growth over the forecast period.
Rapidly improving healthcare infrastructure in developing economies coupled
with unmet patient needs can fuel market growth. In addition, rising cases of
stomach and liver cancer can further stimulate demand for biopsy devices during
the forecast period.
Some of the
leading companies in biopsy devices market are Carefusion Corporation; Devicor
Medical Products, Inc.; Hologic Inc.; C.R. Bard Inc.; and DTR Medical. Most
companies focus on R&D to add technologically advanced and cost effective devices
to their product portfolio. In addition, they are likely to adopt business
strategies such as mergers and acquisitions to expand their business and
geographical reach.
Access
Press Release of Biopsy Devices Market@ www.grandviewresearch.com/press-release/biopsy-devices-market
About
Grand View Research
Grand
View Research, Inc. is a U.S. based market research and consulting company,
registered in the State of California and headquartered in San Francisco.
The company provides syndicated research reports, customized research reports, and consulting services. To help
clients make informed business decisions, we offer market intelligence studies ensuring relevant and
fact-based research across a range of industries, from technology to chemicals,
materials and healthcare.
No comments:
Post a Comment